1 |
CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791.
|
2 |
SU R, WU H, XU B, et al. Developing a multi-dose computational model for drug-induced hepatotoxicity prediction based on toxicogenomics data[J]. IEEE/ACM Trans Comput Biol Bioinform, 2019, 16(4): 1231-1239.
|
3 |
LOW E X S, ZHENG Q, CHAN E, et al. Drug induced liver injury: East versus West - a systematic review and meta-analysis[J]. Clin Mol Hepatol, 2020, 26(2): 142-154.
|
4 |
VINCENZI B, ARMENTO G, SPALATO C M, et al. Drug-induced hepatotoxicity in cancer patients-implication for treatment[J]. Expert Opin Drug Saf, 2016, 15(9): 1219-1238.
|
5 |
DEVARBHAVI H, AITHAL G, TREEPRASERTSUK S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines[J]. Hepatol Int, 2021, 15(2): 258-282.
|
6 |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J].中华肝脏病杂志, 2015, 23(11): 810-820.
|
|
DRUG-INDUCED LIVER DISEASE GROUP OF CHINESE SOCIETY OF HEPATOLOGY. Guidelines for the diagnosis and treatment of drug-induced liver injury[J]. Chin J Hepatol, 2015, 23(11): 810-820.
|
7 |
MOILANEN T, JOKIMÄKI A, TENHUNEN O, et al. Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients[J]. J Cancer Res Clin Oncol, 2018, 144(8): 1613-1621.
|
8 |
CHALASANI N, BONKOVSKY H L, FONTANA R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study[J]. Gastroenterology, 2015, 148(7):1340-1352. e7.
|
9 |
SHU C C, LEE C H, LEE M C, et al. Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre[J]. Int J Tuberc Lung Dis, 2013, 17(7): 934-939.
|
10 |
李雪, 常文千, 崇英之, 等. 乳腺癌化疗药物性肝损伤风险预测模型构建[J].安徽医科大学学报, 2021, 56(9): 1480-1487.
|
|
LI X, CHANG W Q, CHONG Y Z, et al. Construction of risk prediction model for breast cancer chemotherapy drug-induced liver injury[J]. J of Anhui Med Univ, 2021, 56(9): 1480-1487.
|
11 |
董冰, 马保金, 殷晓星. HBV感染的乳腺癌患者化疗后HBV血清学标志物及肝功能变化分析[J]. 中华医院感染学杂志, 2019, 29(6): 864-867.
|
|
DONG B, MA B J, YIN X X. Analysis of HBV serological markers and liver function changes in HBV-infected breast cancer patients after chemotherapy[J]. Chin J Hosp Infect Dis, 2019, 29(6): 864-867.
|
12 |
ZHONG S, YEO W, SCHRODER C, et al. High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy[J]. J Viral Hepat, 2004, 11(1): 55-59.
|
13 |
夏林玉, 徐卫云. 乳腺癌化疗相关性肝损伤的研究进展[J]. 西部医学, 2017, 29(5): 737-740.
|
|
XIA L Y, XU W Y. Research progress of breast cancer chemotherapy-related liver injury[J].West Med, 2017, 29(5): 737-740.
|
14 |
KIM M K, AHN J H, KIM S B, et al. Hepatitis B reactivation during adjuvant anthracycline-based chemotherapy in patients with breast cancer: a single institution's experience[J]. Korean J Intern Med, 2007, 22(4): 237-243.
|
15 |
POWELL E E, WONG V W, RINELLA M. Non-alcoholic fatty liver disease[J]. Lancet, 2021, 397(10290): 2212-2224.
|
16 |
陈凡, 胡述立, 刘剑敏, 等. 伏立康唑相关肝损伤的真实世界研究[J].中国医院药学杂志, 2021, 41(19): 2006-2010.
|
|
CHEN F, HU S L, LIU J M, et al. A real-world study of voriconazole-related liver injury[J]. Chin J Hosp Pharm, 2021, 41(19): 2006-2010.
|
17 |
SWEET P H, KHOO T, NGUYEN S. Nonalcoholic fatty liver disease[J]. Prim Care, 2017, 44(4): 599-607.
|
18 |
SCHLEICHER J, TOKARSKI C, MARBACH E, et al. Zonation of hepatic fatty acid metabolism: the diversity of its regulation and the benefit of modeling[J]. Biochim Biophys Acta, 2015, 1851(5): 641-656.
|
19 |
刘加葳, 李丹, 翟青. 乳腺癌患者化疗致肝损伤的危险因素分析[J].中国癌症杂志, 2021, 31(1): 52-62.
|
|
LIU JW, LI D, ZHAI Q. Analysis of risk factors for liver injury caused by chemotherapy in breast cancer patients[J]. Chin Oncol, 2021, 31(1): 52-62.
|
20 |
赖荣陶, 王晖, 桂红莲, 等. 138例药物性肝损伤患者的临床特征及肝脏组织学改变[J]. 中华肝脏病杂志, 2012, 20(3): 185-189.
|
|
LAI R T, WANG H, GUI H L, et al. Clinical and pathological features in 138 cases of drug-induced liver injury[J]. Zhonghua Gan Zang Bing Za Zhi, 2012, 20(3): 185-189.
|